Skip to main content
. 2013 Jul 18;2013:909045. doi: 10.1155/2013/909045

Table 5.

Stability studies of liquid and solid SMEF.

Formulation Evaluation parameters Observations (months)
0 1 2 3
L-SMEF (F9) Physical appearance Pale yellow clear liquid Pale yellow clear liquid Pale yellow clear liquid Pale yellow clear liquid
Globule size (nm) 127 ± 16 130 ± 24 132 ± 13 133 ± 32
Total drug content 100.0 ± 1.4 99.51 ± 0.9 99.50 ± 1.0 99.48 ± 1.2

S-SMSD Physical appearance White powder White powder White powder White powder
Globule size 133 ± 28 135 ± 42 136 ± 24 136 ± 14
Total drug content 100.0 ± 0.9 99.29 ± 1.2 99.09 ± 1.1 99.02 ± 0.9

S-SMFD Physical appearance White powder White powder White powder White powder
Globule size 160 ± 37 162 ± 23 163 ± 21 165 ± 34
Total drug content 100.0 ± 0.9 99.10 ± 0.8 99.08 ± 1.3 99.03 ± 1.6